Price T Rowe Associates Inc Dynavax Technologies Corp Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 95,537 shares of DVAX stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,537

Previous 85,698 11.48%

Holding current value

$1.07 Million

Previous $1.2 Million 1.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $115,116 - $147,388	9,839 Added 11.48%	95,537 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $106,722 - $122,131	8,153 Added 10.51%	85,698 $1.2 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $42,129 - $49,961	3,333 Added 4.49%	77,545 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $51,870 - $69,353	5,266 Added 7.64%	74,212 $959,000
Q1 2023 May 15, 2023	BUY	$9.44 - $11.88 $20,786 - $26,159	2,202 Added 3.3%	68,946 $677,000

Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $66,693 - $86,305	-6,494 Reduced 8.87%	66,744 $710,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $78,208 - $137,357	7,876 Added 12.05%	73,238 $765,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $98,816 - $170,177	13,264 Added 25.46%	65,362 $823,000
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $197,252 - $292,135	-20,231 Reduced 27.97%	52,098 $565,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $382,114 - $607,553	29,014 Added 66.98%	72,329 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $119,748 - $259,237	-13,073 Reduced 23.18%	43,315 $832,000
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $131,594 - $199,479	-18,151 Reduced 24.35%	56,388 $555,000
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $111,809 - $273,529	-24,466 Reduced 24.71%	74,539 $733,000
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $369,288 - $554,428	99,005 New	99,005 $441,000

Others Institutions Holding DVAX

# of Institutions

269

Shares Held

132M

Call Options Held

326K

Put Options Held

758K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.42B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Dynavax Technologies Corp Transaction History